Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Latest late clinical blogs

Meet our experts at the following events

All late clinical resources

When to Conduct Hepatic Impairment Studies and When Modeling May be Enough

Certara Products – Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Blog

AI, HTA, and the Future of Access: Inside the 12th Annual Kraków HTA Symposium

Market Access, Modeling and Simulation, Blog

Cracking the code on NCA: how Pinnacle 21 helps de-risk PK analyses

Certara Products - Pinnacle 21, Blog

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Certara Products - Simcyp, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Webinar

Enhancing clinical trials with real-world evidence in pregnancy research

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Therapeutic Specialties, Blog

Model Smarter, Not Harder: Introducing Model Designer

Certara Products - Phoenix, Modeling and Simulation, Modeling and Simulation - PK/PD, On-Demand Webinar

The Case for Simulating Pregnancy

Certara Products - Simcyp, Certara Services, Modeling and Simulation, Modeling and Simulation - PBPK, Press Coverage

Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients

Biologics, Modeling and Simulation, Modeling and Simulation - QSP, Publication

Model-Informed Development Accelerates Transformative Treatment for Sleeping Sickness

Certara Services, Rare and Neglected Diseases, Case Study

Certara’s NLME Engine: Setting the Standard for Run Speed and Stability

Certara Products - Phoenix, Fact Sheet

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Certara Products - Certara IQ, Certara Products - Simcyp, Drug Development, Drug-Drug Interactions (DDI), ICH M15, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), On-Demand Webinar

Why ask your CRO to use Pinnacle 21 Enterprise?

Certara Products - Pinnacle 21, Blog
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.